Rituximab intolerance in patients with Waldenström macroglobulinaemia

Br J Haematol. 2016 Aug;174(4):645-8. doi: 10.1111/bjh.13794. Epub 2015 Nov 2.

Authors

Jorge J Castillo^{1

2}, Sandra Kanan³, Kirsten Meid³, Robert Manning³, Zachary R Hunter³, Steven P Treon^{3

4}

Affiliations

¹ Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA. jorgej_castillo@dfci.harvard.edu.
² Harvard Medical School, Boston, MA, USA. jorgej_castillo@dfci.harvard.edu.
³ Bing Center for Waldenström Macroglobulinemia, Dana-Farber Cancer Institute, Boston, MA, USA.
⁴ Harvard Medical School, Boston, MA, USA.

PMID: 26523929
DOI: 10.1111/bjh.13794

No abstract available

Keywords: Lymphoplasmacytic lymphoma; Waldenstrom macroglobulinaemia; infusion; rituximab.

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Drug Tolerance*
Female
Humans
Male
Middle Aged
Retrospective Studies
Rituximab / pharmacology*
Waldenstrom Macroglobulinemia / drug therapy*

Substances

Rituximab